Imsidolimab (Anti-IL-1RL2 / IL-36R)

Imsidolimab (Anti-IL-1RL2 / IL-36R) is a high-affinity, humanized monoclonal antibody targeting IL-36R. It has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases. MW :150 KD.
Supplier Selleck Chemicals
Product # A2667
Sku # A2667-1mg*25
Pricing 1mg*25, $5070.00
Feedback